Learn More
Medchemexpress LLC 2,6-dichloro-4-[2-(1-piperazinyl)-4-pyridinyl]-N-(trimethylpyrazol-4-yl)-benzenesulfonamide | 1215010-55-1 | 99.7% | 495.43 g/mol | C21H24Cl2N6O2S | 25 MG

Supplier: Medchemexpress LLC HY10305625MG
DDD85646 (IMP-366) is an orally active inhibitor of N-myristoyltransferase (NMT) with potent enzymatic activity against Trypanosoma brucei (TbNMT IC50 = 2 nM) and measurable activity versus human NMT (hNMT IC50 = 4 nM). It is supplied as a high-purity research compound for in vitro and in vivo pharmacology studies targeting NMT.
- Potent N-myristoyltransferase inhibition (TbNMT IC50 = 2 nM; hNMT IC50 = 4 nM).
- High purity suitable for research (reported ≥99.7%).
- Soluble in DMSO (100 mg/mL); recommended in vivo formulations provided for dosing.
- Available in small research pack sizes, suitable for preclinical studies.
- Powder stable at -20°C for long-term storage; solutions should be aliquoted and stored cold.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.